REG - Physiomics PLC - Director Dealing
RNS Number : 8427VPhysiomics PLC12 August 202012 August 2020
Physiomics plc
("Physiomics") or ("the Company")
Director Dealing
The Company announces that it received notice today that Dr Jim Millen sold 597,332 ordinary shares in the Company at 6.45p per share to cover the cost of his exercise of options announced on 5 August 2020.
Following the sale of shares, the total holdings of Dr Jim Millen will be 1,386,947, representing approximately 1.42 per cent. of the Company's issued share capital.
The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.
Enquiries:
Physiomics plc
Dr Jim Millen, CEO
+44 (0)1865 784 980
Hybridan LLP (broker)
Claire Louise Noyce
+44 (0) 203 764 2341
Strand Hanson Ltd (NOMAD)
Richard Tulloch & James Dance
+44 (0)20 7409 3494
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
James Millen
2
Reason for the notification
a)
Position/status
Director, CEO
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Physiomics plc
b)
LEI
213800A71DSZ6ABMTQ91
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares
GB00BDR6W943
b)
Nature of the transaction
Disposal of shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
6.45p
597,332
d)
Aggregated information
- Aggregated volume
- Price
597,332
At 6.45p per share
e)
Date of the transaction
11-8-2020
f)
Place of the transaction
XLON, AIM
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDDSHPBMRTMTJBBFM
Recent news on Physiomics
See all newsREG - Physiomics PLC - Trading Update
AnnouncementRCS - Physiomics PLC - IMC Presentation on Company Website
AnnouncementREG - Physiomics PLC - Contract Award
AnnouncementREG - Physiomics PLC - Interim Results
AnnouncementRCS - Physiomics PLC - Notice of Results and Investor Presentation
Announcement